Accutar Biotechnology Inc
Accutar is a clinical stage biotech headquartered in NJ, focusing on AI-empowered drug discovery and Targeted Protein Degrader (TPD) platform. As one of the leaders in the TPD space, Accutar successfully pushed into clinics chimeric degraders against 3 targets.
At ACS, we introduce ChemiRise, a ML based retrosynthesis and feasibility tool, and PatentGPT for accurate reading, extraction, and analysis of patents. Both tools will enhance internal medchem capabilities.
Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Appointment Request
Blocked Timeslot
Restricted Timeslot
For Exhibitor and Sponsorship questions, please contact expo@acs.org